Summit X LLC’s Accendra Health ACH Stock Holding History

Summit X LLC’s Portfolio ACH Stock Details ACH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,034	Closed	-$118K	–	266
2025 Q1	$118K	Buy	+13,034	New	+$138K	0.02%	238
2023 Q3	–	Sell	-20,758	Closed	-$395K	–	252
2023 Q2	$395K	Hold	20,758	–	–	0.1%	183
2023 Q1	$302K	Buy	20,758 +27	+0.1%	+$484	0.08%	207
2022 Q4	$652K	Hold	20,731	–	–	0.19%	116
2022 Q3	$499K	Hold	20,731	–	–	0.15%	153
2022 Q2	$652K	Hold	20,731	–	–	0.19%	115
2022 Q1	$912K	Sell	20,731 -350	-2%	-$15K	0.22%	93
2021 Q4	$916K	Sell	21,081 -2,058	-9%	-$80.7K	0.21%	105
2021 Q3	$724K	Buy	23,139 +2,099	+10%	+$82.6K	0.18%	120
2021 Q2	$891K	Buy	21,040 +1,040	+5%	+$40.5K	0.23%	107
2021 Q1	$752K	Hold	20,000	–	–	0.21%	111
2020 Q4	$541K	Hold	20,000	–	–	0.16%	137
2020 Q3	$25	Buy	20,000 +10,000	+100%	+$146K	﹤0.01%	435
2020 Q2	$76K	Buy	+10,000	New	+$73.2K	0.03%	197
2018 Q3	–	Sell	-10,729	Closed	-$181K	–	232
2018 Q2	$181K	Buy	+10,729	New	+$174K	0.1%	198

Other funds holding ACH

CCM

Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Summit X LLC's ACH Position: Q2 2025 in Review

Summit X LLC sold out of Accendra Health (ACH) in Q2 2025, closing a stake of 13,034 shares — an estimated $118K sold.

Summit X LLC first reported a position in ACH in Q2 2018 and held it in 15 quarters. The position peaked at $916K in Q4 2021. 234 funds tracked by Wall St. Rank hold ACH as of Q2 2025.

Summit X LLC reported no remaining Accendra Health position as of Q2 2025 after selling out during the quarter.
Summit X LLC sold 13,034 Accendra Health shares in Q2 2025, an estimated $118K.
Summit X LLC first reported a position in Accendra Health in Q2 2018 and held it in 15 quarters.
Summit X LLC's Accendra Health position peaked at $916K in Q4 2021.
234 funds tracked by Wall St. Rank held Accendra Health as of Q2 2025.

Based on Summit X LLC's 13F filing for Q2 2025, filed 7 Aug 2025.